How to use Cipla everolimus in India? What's the price?

Everolimus, a highly effective targeted therapeutic drug targeting themTOR signaling pathway, has shown significant efficacy in the treatment of a variety of cancers and tuberous sclerosis complex (TSC)-related diseases, bringing new hope to many patients. In particular, the generic version of everolimus produced by Cipla Pharmaceuticals in India has received widespread attention for its affordable price and reliable quality.

So, how to use everolimus in India for patients with different diseases? For patients with most cancers, including breast cancer, neuroendocrine tumors, and renal cell carcinoma, the recommended daily dose is 10 mg taken orally once and continued until disease progression or unacceptable toxicity. For tuberous sclerosis complex (TSC)-related renal angiomyolipoma, the same dose of 10 mg orally once daily is used. When treating tuberous sclerosis complex (TSC)-related subependymal giant cell astrocytoma and partial-onset epilepsy, the starting dose needs to be adjusted based on the patient's body surface area to ensure the accuracy and safety of the treatment. Patients must strictly follow the doctor's instructions during medication. If they have any questions or discomfort, they should communicate with the doctor in time.

In terms of price, the Indian version of Cipla everolimus provides a more affordable option. A box of 10mg*10 tablets is priced at more than a thousand yuan; a box of 5mg*10 tablets is slightly lower, about eight or nine hundred yuan. Such a price, compared with the original drug, undoubtedly reduces the financial burden on patients, allowing more patients to afford long-term treatment.

However, patients should exercise caution when purchasing the Indian version of everolimus. Be sure to purchase medicines through formal channels to ensure the quality and safety of medicines. At the same time, patients should pay close attention to their physical condition during the medication, and report to the doctor immediately if any symptoms of discomfort occur. The doctor will promptly adjust the treatment plan according to the patient's actual condition to ensure that the patient gets the best treatment effect.

Overall, the Indian version of everolimus, Cipla, offers patients a trustworthy treatment option with its affordable price and reliable quality. However, patients still need to strictly abide by the doctor's instructions during medication to ensure the safety and effectiveness of the medication.